- Home
- WHLR vs ONCO Comparison
WHLR vs ONCO Comparison
Compare WHLR & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- ONCO
- Stock Information
- Founded
- WHLR 2011
- ONCO 2018
- Country
- WHLR United States
- ONCO United States
- Employees
- WHLR 52
- ONCO N/A
- Industry
- WHLR Real Estate Investment Trusts
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- ONCO Health Care
- Exchange
- WHLR Nasdaq
- ONCO Nasdaq
- Market Cap
- WHLR 5.1M
- ONCO 9.4M
- IPO Year
- WHLR 2012
- ONCO 2022
- Fundamental
- Price
- WHLR $4.51
- ONCO $0.55
- Analyst Decision
- WHLR
- ONCO
- Analyst Count
- WHLR 0
- ONCO 0
- Target Price
- WHLR N/A
- ONCO N/A
- AVG Volume (30 Days)
- WHLR 1.2M
- ONCO 9.9M
- Earning Date
- WHLR 03-04-2025
- ONCO 04-10-2025
- Dividend Yield
- WHLR N/A
- ONCO N/A
- EPS Growth
- WHLR N/A
- ONCO N/A
- EPS
- WHLR N/A
- ONCO N/A
- Revenue
- WHLR $102,749,000.00
- ONCO $1,870,605.00
- Revenue This Year
- WHLR N/A
- ONCO N/A
- Revenue Next Year
- WHLR N/A
- ONCO N/A
- P/E Ratio
- WHLR N/A
- ONCO N/A
- Revenue Growth
- WHLR N/A
- ONCO N/A
- 52 Week Low
- WHLR $3.89
- ONCO $0.32
- 52 Week High
- WHLR $3,801.60
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- WHLR 24.70
- ONCO 44.65
- Support Level
- WHLR $3.89
- ONCO $0.53
- Resistance Level
- WHLR $4.79
- ONCO $0.70
- Average True Range (ATR)
- WHLR 0.76
- ONCO 0.06
- MACD
- WHLR 0.45
- ONCO 0.00
- Stochastic Oscillator
- WHLR 15.77
- ONCO 22.17
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.